For the trans-targets of lncRNAs and target mRNAs, Parkinson's disease, herpes simplex infection, HTLV-I infection, Rheumatoid arthritis, nonalcoholic fatty liver disease, p53 signaling pathway, RIG-I-like receptor signaling pathway,and nonalcoholic fatty liver disease were identified (Figure 6(b)). The gene discussed is TP53; the disease is metabolic dysfunction-associated steatotic liver disease.